Atlas Trials

The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.

Clinical trial NCT06600412 · RECRUITING

Trial details

NCT number
NCT06600412
Sponsor
River 3 Renal Corp.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Kidney Disease
Start date
2024-10-10
Primary completion
2027-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.